active
ACTIVE SINCE: 2016

Increasing access to treatment for people living with CML and Ph+ALL

BMS collaborates with the Max Foundation to increase access to dasatinib for people living with Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) in more than 20 LMICs
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Global NGOs 1
  • BMS collaborates with the Max Foundation to increase access to dasatinib for people living with Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) in more than 20 LMICs. This access pathway is specifically designed to help patients who are uninsured or underinsured, where product is not available commercially, where significant access hurdles exist and where local market initiatives cannot enable access to the therapy.
  • BMS provides dasatinib free of charge to organizations that reach a patient population with an expressed need. Organizations that are provided bulk product donations for patient must have infrastructure to be able to appropriately receive and deploy product.For example, The Max Foundation is provided with  dasatinib, administered free of charge within the LMICs and in accordance with medical best practices and with the Max Access Solutions Product Donation Guidelines with an expressed need within the LMICs and in accordance with medical best practices. For example, BMS provides  the Max Access Solutions Product Donation Guidelines. Max upholds high quality standards for ensuring that patient receive Product. (For more information, see The Max Access Solutions Guidelines
Results and milestones
  • To date, 1,222 patients with CML and Ph+ALL have been helped  in over 29 countries.

 

Geographic Reach
  • Africa
  • Americas
  • Europe
  • South-East Asia
  • Western Pacific
See Where
Disease Area
  • Non-communicable diseases
See Disease Areas
Target Population
  • Other
Partner organizations
Global NGOs
The Max
Foundation

The Max Foundation upholds high quality standards for ensuring that patient receive Product. For more information, see The Max Access Solutions Guidelines: https://www.themaxfoundation.org/max-access-solutions-guidelines/#_edn2